
MAIA Biotechnology, Inc. Appoints Joseph F. McGuire as Chief Financial Officer and Provides Corporate Update
CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company focused on developing potential first-in-class oncology drugs (“MAIA”), announced today that it has appointed Joseph F. […]
